| pubmed-article:19192667 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19192667 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19192667 | lifeskim:mentions | umls-concept:C0008838 | lld:lifeskim |
| pubmed-article:19192667 | lifeskim:mentions | umls-concept:C0015133 | lld:lifeskim |
| pubmed-article:19192667 | lifeskim:mentions | umls-concept:C0016360 | lld:lifeskim |
| pubmed-article:19192667 | lifeskim:mentions | umls-concept:C0023413 | lld:lifeskim |
| pubmed-article:19192667 | lifeskim:mentions | umls-concept:C0278562 | lld:lifeskim |
| pubmed-article:19192667 | lifeskim:mentions | umls-concept:C0596545 | lld:lifeskim |
| pubmed-article:19192667 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:19192667 | pubmed:issue | 6B | lld:pubmed |
| pubmed-article:19192667 | pubmed:dateCreated | 2009-2-5 | lld:pubmed |
| pubmed-article:19192667 | pubmed:abstractText | A retrospective analysis was carried out on the efficacy and toxicity of the combination of 5-fluorouracil, leucovorin, etoposide and cisplatin (FLEP) in patients with metastatic esophageal cancer treated at our institution. | lld:pubmed |
| pubmed-article:19192667 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19192667 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19192667 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19192667 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19192667 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19192667 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19192667 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19192667 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19192667 | pubmed:issn | 0250-7005 | lld:pubmed |
| pubmed-article:19192667 | pubmed:author | pubmed-author:PragerGerhard... | lld:pubmed |
| pubmed-article:19192667 | pubmed:author | pubmed-author:RadererMarkus... | lld:pubmed |
| pubmed-article:19192667 | pubmed:author | pubmed-author:Ba-SsalamahAh... | lld:pubmed |
| pubmed-article:19192667 | pubmed:author | pubmed-author:ZacherlJohann... | lld:pubmed |
| pubmed-article:19192667 | pubmed:author | pubmed-author:HejnaMichaelM | lld:pubmed |
| pubmed-article:19192667 | pubmed:author | pubmed-author:JonakConstanz... | lld:pubmed |
| pubmed-article:19192667 | pubmed:author | pubmed-author:TrochMarleneM | lld:pubmed |
| pubmed-article:19192667 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:19192667 | pubmed:volume | 28 | lld:pubmed |
| pubmed-article:19192667 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19192667 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19192667 | pubmed:pagination | 4101-4 | lld:pubmed |
| pubmed-article:19192667 | pubmed:meshHeading | pubmed-meshheading:19192667... | lld:pubmed |
| pubmed-article:19192667 | pubmed:meshHeading | pubmed-meshheading:19192667... | lld:pubmed |
| pubmed-article:19192667 | pubmed:meshHeading | pubmed-meshheading:19192667... | lld:pubmed |
| pubmed-article:19192667 | pubmed:meshHeading | pubmed-meshheading:19192667... | lld:pubmed |
| pubmed-article:19192667 | pubmed:meshHeading | pubmed-meshheading:19192667... | lld:pubmed |
| pubmed-article:19192667 | pubmed:meshHeading | pubmed-meshheading:19192667... | lld:pubmed |
| pubmed-article:19192667 | pubmed:meshHeading | pubmed-meshheading:19192667... | lld:pubmed |
| pubmed-article:19192667 | pubmed:meshHeading | pubmed-meshheading:19192667... | lld:pubmed |
| pubmed-article:19192667 | pubmed:meshHeading | pubmed-meshheading:19192667... | lld:pubmed |
| pubmed-article:19192667 | pubmed:meshHeading | pubmed-meshheading:19192667... | lld:pubmed |
| pubmed-article:19192667 | pubmed:meshHeading | pubmed-meshheading:19192667... | lld:pubmed |
| pubmed-article:19192667 | pubmed:meshHeading | pubmed-meshheading:19192667... | lld:pubmed |
| pubmed-article:19192667 | pubmed:meshHeading | pubmed-meshheading:19192667... | lld:pubmed |
| pubmed-article:19192667 | pubmed:meshHeading | pubmed-meshheading:19192667... | lld:pubmed |
| pubmed-article:19192667 | pubmed:articleTitle | The combination of 5-fluorouracil, leukovorin, etoposide, and cisplatin (FLEP) in patients with metastatic esophageal cancer. A single-institution experience. | lld:pubmed |
| pubmed-article:19192667 | pubmed:affiliation | Department of Internal Medicine I, Division of Oncology, Medical University of Vienna, A-1090 Vienna, Austria. | lld:pubmed |
| pubmed-article:19192667 | pubmed:publicationType | Journal Article | lld:pubmed |
